As the end of the Transition Period on 31st December 2020 draws ever closer, pharmaceutical companies are preparing for life outside the EU Single Market and Customs Union. Holding additional stock could provide a buffer against any potential border disruption that could occur during the transition to the controls that…

  As from 1st June we are distributing products to hospitals on behalf of Hikma Pharmaceuticals, adding to our growing portfolio of products and manufacturers.   If you are a manufacturer or hospital and want to know more about how Mawdsleys can support and work with you, contact us today…